DK2029561T3 - Tricyclisk forbindelse og farmaceutisk anvendelse deraf - Google Patents

Tricyclisk forbindelse og farmaceutisk anvendelse deraf

Info

Publication number
DK2029561T3
DK2029561T3 DK07767453.9T DK07767453T DK2029561T3 DK 2029561 T3 DK2029561 T3 DK 2029561T3 DK 07767453 T DK07767453 T DK 07767453T DK 2029561 T3 DK2029561 T3 DK 2029561T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical use
tricyclic compound
tricyclic
compound
pharmaceutical
Prior art date
Application number
DK07767453.9T
Other languages
English (en)
Inventor
Osamu Uchikawa
Tatsuki Koike
Yasutaka Hoashi
Takafumi Takai
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of DK2029561T3 publication Critical patent/DK2029561T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK07767453.9T 2006-06-19 2007-06-18 Tricyclisk forbindelse og farmaceutisk anvendelse deraf DK2029561T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006168518 2006-06-19
PCT/JP2007/062645 WO2007148808A1 (en) 2006-06-19 2007-06-18 Tricyclic compound and pharmaceutical use thereof

Publications (1)

Publication Number Publication Date
DK2029561T3 true DK2029561T3 (da) 2014-11-10

Family

ID=38519675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07767453.9T DK2029561T3 (da) 2006-06-19 2007-06-18 Tricyclisk forbindelse og farmaceutisk anvendelse deraf

Country Status (36)

Country Link
US (5) US8030337B2 (da)
EP (1) EP2029561B1 (da)
JP (1) JP5222737B2 (da)
KR (1) KR101442274B1 (da)
CN (1) CN101506181B (da)
AR (1) AR061478A1 (da)
AU (1) AU2007261953B2 (da)
BR (1) BRPI0713743C1 (da)
CA (1) CA2655753C (da)
CL (1) CL2007001779A1 (da)
CO (1) CO6150175A2 (da)
CR (1) CR10524A (da)
CY (1) CY1115729T1 (da)
DK (1) DK2029561T3 (da)
ES (1) ES2523410T3 (da)
GE (1) GEP20125392B (da)
HK (1) HK1130049A1 (da)
HR (1) HRP20141046T1 (da)
IL (1) IL195639A0 (da)
JO (1) JO2999B1 (da)
MA (1) MA30523B1 (da)
ME (2) ME00582A (da)
MX (1) MX2008015842A (da)
MY (1) MY158069A (da)
NO (1) NO341739B1 (da)
NZ (1) NZ574037A (da)
PE (1) PE20080941A1 (da)
PL (1) PL2029561T3 (da)
PT (1) PT2029561E (da)
RS (1) RS53616B1 (da)
RU (1) RU2456278C2 (da)
SI (1) SI2029561T1 (da)
TW (1) TWI402261B (da)
UA (1) UA99104C2 (da)
WO (1) WO2007148808A1 (da)
ZA (1) ZA200900151B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR061478A1 (es) * 2006-06-19 2008-08-27 Takeda Pharmaceutical Compuesto triciclico y composicion farmaceutica
EP2098513B1 (en) * 2006-12-28 2015-01-21 Takeda Pharmaceutical Company Limited Tricyclic compound and pharmaceutical use thereof
CN103450111B (zh) * 2013-09-04 2015-07-08 温州大学 一种苯并噻唑杂环化合物的绿色合成方法
US20160253891A1 (en) * 2015-02-27 2016-09-01 Elwha Llc Device that determines that a subject may contact a sensed object and that warns of the potential contact
KR20180100627A (ko) 2016-01-08 2018-09-11 다케다 야쿠힌 고교 가부시키가이샤 섬망의 예방 또는 치료제
WO2017119455A1 (ja) * 2016-01-08 2017-07-13 武田薬品工業株式会社 自閉症スペクトラム障害の予防または治療剤
WO2018075649A1 (en) 2016-10-19 2018-04-26 Monsanto Technology Llc Compositions and methods for altering flowering and plant architecture to improve yield potential

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292226C (en) * 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
FR2680366B1 (fr) 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5654325A (en) 1993-11-18 1997-08-05 Eli Lilly And Company Melatonin derivatives for use in treating sleep disorders
US6180657B1 (en) 1993-11-18 2001-01-30 Eli Lilly And Company Melatonin derivatives for use in treating desynchronization disorders
FR2725985B1 (fr) 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE19502895A1 (de) 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
US5753709A (en) 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
CA2176854A1 (en) 1995-06-07 1996-12-08 Daniel J. Keavy N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
US5596019A (en) 1995-06-07 1997-01-21 Bristol-Myers Squibb Company N-acyl-cycloalkylamine derivatives as melatonergics
FR2742153B1 (fr) 1995-12-12 1998-02-13 Innothera Lab Sa Utilisation de derives tricycliques du 1,4-dihydro-1,4- dioxo-1h-naphtalene, nouveaux composes obtenus et leur application en therapeutique
US6034239A (en) 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
NZ330656A (en) 1996-03-08 1999-06-29 Takeda Chemical Industries Ltd Tricyclic compounds, their production and use
SE9802360D0 (sv) * 1998-07-01 1998-07-01 Wikstroem Hakan Vilhelm New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins ((basic)-N-substituted and (basic)-N,N-disubstituted derivatives of 2,6-diamino-thiazolo(4,5-f)indan and 2,7-di-amino-thiazolo(4,5-g)tetralin
DE60043017D1 (de) * 1999-08-20 2009-11-05 Takeda Pharmaceutical Zusammensetzung für perkutane Absorption mit einem melantoninrezeptor-agonistisch wirkendem Wirkstoff
EP2305219A1 (en) * 2000-11-17 2011-04-06 Takeda Pharmaceutical Company Limited Pharmaceutical preparations coated with a copolyvidone-containing coating
JP3633895B2 (ja) * 2000-11-17 2005-03-30 武田薬品工業株式会社 コポリビドン含有製剤
US6569894B1 (en) 2001-10-04 2003-05-27 Bristol-Myers Squibb Company Arylalkylbenzofuran derivatives as melatonergic agents
US6737431B2 (en) 2002-03-12 2004-05-18 Bristol-Myers Squibb Company Benzoxazole derivatives as novel melatonergic agents
US20050197365A1 (en) * 2004-02-27 2005-09-08 Jeffrey Sterling Diamino thiazoloindan derivatives and their use
US20060223877A1 (en) 2005-03-31 2006-10-05 Zemlan Frank P Methods of treatment utilizing certain melatonin derivatives
AR061478A1 (es) * 2006-06-19 2008-08-27 Takeda Pharmaceutical Compuesto triciclico y composicion farmaceutica

Also Published As

Publication number Publication date
WO2007148808A1 (en) 2007-12-27
EP2029561B1 (en) 2014-08-13
JO2999B1 (ar) 2016-09-05
BRPI0713743B8 (pt) 2020-05-19
PE20080941A1 (es) 2008-09-04
CL2007001779A1 (es) 2008-01-04
BRPI0713743A2 (pt) 2012-11-06
MX2008015842A (es) 2009-01-09
US8349879B2 (en) 2013-01-08
US20110196003A1 (en) 2011-08-11
RU2009101299A (ru) 2010-07-27
CY1115729T1 (el) 2017-01-25
AR061478A1 (es) 2008-08-27
NO341739B1 (no) 2018-01-15
MA30523B1 (fr) 2009-06-01
US8236837B2 (en) 2012-08-07
EP2029561A1 (en) 2009-03-04
CN101506181B (zh) 2011-12-07
BRPI0713743C1 (pt) 2021-05-25
BRPI0713743B1 (pt) 2020-03-17
TW200815376A (en) 2008-04-01
KR20090023701A (ko) 2009-03-05
RS53616B1 (en) 2015-04-30
CA2655753C (en) 2015-08-04
ME01998B (me) 2015-05-20
IL195639A0 (en) 2009-09-01
NZ574037A (en) 2011-10-28
US20140011849A1 (en) 2014-01-09
GEP20125392B (en) 2012-02-10
US20130079374A1 (en) 2013-03-28
ES2523410T3 (es) 2014-11-25
CA2655753A1 (en) 2007-12-27
CR10524A (es) 2009-01-27
CN101506181A (zh) 2009-08-12
ZA200900151B (en) 2010-03-31
KR101442274B1 (ko) 2014-09-22
PL2029561T3 (pl) 2015-03-31
NO20090234L (no) 2009-02-12
PT2029561E (pt) 2014-11-12
US20090182023A1 (en) 2009-07-16
HK1130049A1 (en) 2009-12-18
AU2007261953A1 (en) 2007-12-27
JP5222737B2 (ja) 2013-06-26
US8030337B2 (en) 2011-10-04
HRP20141046T1 (hr) 2014-12-19
US8552037B2 (en) 2013-10-08
MY158069A (en) 2016-08-30
US8895591B2 (en) 2014-11-25
TWI402261B (zh) 2013-07-21
CO6150175A2 (es) 2010-04-20
AU2007261953B2 (en) 2012-11-08
SI2029561T1 (sl) 2014-11-28
ME00582A (en) 2011-12-20
JP2009541202A (ja) 2009-11-26
US20110190361A1 (en) 2011-08-04
RU2456278C2 (ru) 2012-07-20
UA99104C2 (uk) 2012-07-25

Similar Documents

Publication Publication Date Title
BRPI0715712A2 (pt) Composição farmacêutica
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
DK2079485T3 (da) Phenylpropionamidforbindelser og anvendelsen deraf
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK1884242T3 (da) Farmaceutisk sammensætning omfattende lurasidon
BRPI0719393A2 (pt) Composição farmacêutica
DK2041139T3 (da) Farmaceutiske forbindelser
DK2343071T3 (da) Farmaceutiske doseringsformer
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
DK1957073T3 (da) Lægemiddel
DK2081955T3 (da) Metastinderivater og anvendelse deraf
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
BRPI0716445A2 (pt) composiÇço farmacÊutica
CR10725A (es) Compuestos de pirazolina y su uso y composiones farmaceuticas
DK2254873T3 (da) Benzodiazepinforbindelse og farmaceutisk sammensætning.
BRPI0720234A2 (pt) Composição farmacêutica
DK2207773T3 (da) Heterocyklisk forbindelse og farmaceutisk sammensætning deraf.
DK1829874T3 (da) Tricyklisk forbindelse og anvendelse deraf
DK1885716T3 (da) Thiazolderivater og anvendelse deraf
DK3181691T3 (da) Anti-fgf23-antistof og en farmaceutisk sammensætning omfattende samme
DK2152699T3 (da) Quinolon-forbindelse og farmaceutisk sammensætning
DK2029561T3 (da) Tricyclisk forbindelse og farmaceutisk anvendelse deraf
EP2098513A4 (en) TRICYCLIC COMPOUND AND ITS PHARMACEUTICAL USE
BRPI0810057A2 (pt) Composição farmacêutica contendo floroglucinol e paracetamol
DK2231603T3 (da) Substituerede 3-hydroxypyridiner og farmaceutiske sammensætninger deraf